The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...
As you say, not all trials found a benefit, but the largest trial found that intrathecal injections — which are similar to ...
(HealthDay News) — The US Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults ... and misuse. “Treatment-resistant depression can be very complicated ...
The results? A nasal spray of oxytocin significantly reduced acute feelings of loneliness in participants, especially during group therapy sessions, even months after treatment. In the study ...
The FDA's expanded approval will allow the drug to be more accessible with insurance. Parkside Psychiatric Hospital in Tulsa has an on-site Spravato outpatient clinic that sees over 20 patients ...
Electrical Nerve Stimulation Eases Long COVID Pain and Fatigue, Study Finds Nov. 25, 2024 — A wearable electrical nerve stimulation device can provide relief to people experiencing the ...
If you're struggling to pay your bills, you might be able to lower your payments by working with a debt relief company specializing in debt settlement. Unlike debt consolidation, which merges ...
An estimated 21 million American adults suffer from clinical depression. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...
And now there’s a new option for treatment: Spravato, a nasal spray that’s been shown to give rapid relief to depression symptoms, was just approved as a stand-alone therapy by the Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback